Either RXMD will demonstrate that they return value for long-term shareholders, and that their company is continuing to grow, or they won't. If they don't, there is no cushion big enough, they will start their own death spiral. I'm betting that RXMD management is smarter than that.
Go RXMD!
I'm here to discover news and share opinions with other investors. All of my posts are my opinions and derivatives.